Bahgat, Maged M

El-Gammal, Nahla E

Emara, Mohamed H

Mohamed, Lamiaa A

Virology Journal

English

PubMed

Mohamed H Emara

Nahla E El-Gammal

Lamiaa A Mohamed

Maged M Bahgat

Crossref

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy

Springer - Publisher Connector

Brechot C: Persistence of hepatitis B and hepatitis C viral genomes in primary liver Emara et al.

Chu CM: Response of patients with dual hepatitis B virus and C virus infection to interferon therapy.

CL: Therapeutic Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Occult Hepatitis B Virus Dual infection.

Co-infection by serologically silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver.

DS: Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int

Dusheiko G: Occult hepatitis B virus infection does not affect liver histology orresponse to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol

El Ghannam M: Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis. J Viral Hepat

El-Saharnouby A: HCV Genotype and “Silent” HBV coinfection: Two main risk factors for a more severe liver disease. Tanta Medi Sci J

Epidemiology of HCV in Egypt. The Afro-Arab Liver journal

European Association for the Study of the Liver EASL Clinical Practice Guidelines: Management of chronic hepatitis

Gentilini P: Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection. Arch Virol

Group: Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology

Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clinical Virol

Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology

Madwar MA: Hepatitis C genotyping versus serotyping in Egyptian patients. Infection

Med Virol

Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.

N: A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology

Nonresponse to treatment for hepatitis C: current management strategies. Drugs

Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Occult hepatitis B virus infection: A case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood Transfus

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult&quot;? Hepatol

Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther

Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatol

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol

Significance of isolated hepatitis C core antibody in blood donors. Arch Intern Med

Squadrito G: Occult hepatitis B virus infection.

T: Fibrosis progression in chronic hepatitis C patients with occult hepatitis B coinfection. J Clin Virol

The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology

The French METAVIR Cooperative Study Group: An algorithm for grading activity in chronic hepatitis C. Hepatology

Thiel D: The impact of previous HBV infection on the course of chronic hepatitis C.

Zoulim F: Analysis of HCV co- infection with occult hepatitis B virus in patients undergoing IFN therapy.

Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepato

file:///data/core-remote/dit/data/Springer-OA/pdf/9b1/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvMTc0My00MjJYLTctMzI0LnBkZg==.pdf

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy

Abstract

Similar works

Full text

Available Versions

Crossref

Springer - Publisher Connector